skip to Main Content

IPRs to Leave Their Comfort Zone

Introduction: While facing a bolt from the blue in the form of the devastating COVID-19 pandemic, when the repurposed drugs and the vaccines that are getting developed by the incessant efforts of health professionals around the globe, were the only…

The Pandemic and the Vaccine- Licensing Rights in Patent

The first case of novel coronavirus or COVID-19 is estimated to have first occurred at the seafood market of Wuhan, China in December 2019. Little did everyone know that the virus which was first mistaken as the common flu was…

Covid-19: Patent, Economy, Prophylaxis and Treatment

Everyone around the globe is suffering from the Covid-19 pandemic and several industries are trying to overcome the economic turmoil.There is a steep decline in product sales & product manufacturing segments, Covid-19 and worldwide lockdowns has severely affected R&D activities…

Patent Pooling In The Wake Of Covid-19

Efforts around the world to fight the Covid-19 pandemic have led to an unprecedented amount of collaborative research work. Platforms like GISAID and preprint servers are thriving with research work and new information on the novel Coronavirus. The data and…

Israel Issuing Compulsory License During The Time Of Covid 19 Pandemic

COVID-19 Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is the name given to the 2019 novel coronavirus. COVID-19 (Corona Virus Disease 2019) is  the name given to the disease related to the virus. COVID 19 is a new sort of virus belonging to the family of corona viruses, that has not…

Back To Top